Metraipolis › archive › dc_dd27eea77708

Clinical characteristics and prognostic impact of HER2-ultralow breast cancer and tumor-infiltrating lymphocytes (TILs) — Europe PMC PMID:41316049

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41316049
DOI
10.1186/s12885-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-11-08T04:53:13.615Z
SHA-256 of the archived text
f068707e8ce8d7817b3f520a059408c720fbbf8225e68eead5151b7514b645c0
Stable URL of this page
https://metraipolis.com/documento/dc_dd27eea77708

How to cite

Clinical characteristics and prognostic impact of HER2-ultralow breast cancer and tumor-infiltrating lymphocytes (TILs) — Europe PMC PMID:41316049 — Europe PMC (en), https://europepmc.org/article/MED/41316049 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dd27eea77708 (Metraipolis archive dc_dd27eea77708, sha256 f068707e8ce8d7817b3f520a059408c720fbbf8225e68eead5151b7514b645c0)
BibTeX
@misc{dcdd27eea77708,
  title = {Clinical characteristics and prognostic impact of HER2-ultralow breast cancer and tumor-infiltrating lymphocytes (TILs) — Europe PMC PMID:41316049},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41316049},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dd27eea77708; sha256 f068707e8ce8d7817b3f520a059408c720fbbf8225e68eead5151b7514b645c0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41316049. Agents can read the archived copy with the MCP tool read_document.